4 completed, 1 terminated, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Mixed Dementias: new trials by email Literature Review of Mixed Dementias trials Research Report on Mixed Dementias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol's Role in Dementia Management Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed | Phase 2 / Phase 3 | Unknown | Hospital Pengajar Universiti Putra Malaysia | 486 | 2024-09-01 | 2024-07-23 |
| Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia Donepezil - Dementia, Vascular, Dementia, Mixed | Phase 3 | Terminated | Pfizer | 149 | 2005-06-01 | 2015-03-24 |
| A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia galantamine hydrobromide - Alzheimer Disease, Vascular Dementia | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 593 | 1998-12-01 | 2011-05-18 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia Risperidone - Dementia, Alzheimer Disease | Phase 3 | Completed | Janssen-Cilag Pty Ltd | 344 | 1998-03-01 | 2010-11-19 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia risperidone - Dementia, Alzheimer Disease | Phase 3 | Completed | Janssen Pharmaceutica N.V., Belgium | 349 | 1995-04-01 | 2011-01-14 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia risperidone - Dementia, Alzheimer Disease | Phase 3 | Completed | Janssen, LP | 626 | 2010-12-03 |
Dementia, Vascular (6) · Alzheimer Disease (4) · Dementia (3)
Arterial Occlusive Diseases (6) · Arteriosclerosis (6) · Brain Diseases (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Intracranial Arterial Diseases (6) · Intracranial Arteriosclerosis (6) · Leukoencephalopathies (6) · Mental Disorders (6) · Nervous System Diseases (6) · Neurocognitive Disorders (6) · Vascular Diseases (6) · Neurodegenerative Diseases (4) · Tauopathies (4)
Risperidone (3) · Cannabidiol (1) · Donepezil (1) · Galantamine (1)
Hospital Pengajar Universiti Putra Malaysia (1) · Janssen Pharmaceutica N.V., Belgium (1) · Janssen, LP (1) · Janssen-Cilag Pty Ltd (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Pfizer (1)
Canada (1) · Malaysia (1)
PMID 10084637, PMID 10496251, PMID 11965273, PMID 12633121, PMID 36791792, PMID 39498781